A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.
Twiss
I M
IM
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
van den Berk
A H M
AH
de Kam
M L
ML
Bosch
J J
JJ
Cohen
A F
AF
Vermeij
P
P
Burggraaf
J
J
D000328:Adult; D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D018592:Cross-Over Studies; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D000077268:Pamidronate; D016037:Single-Blind Method
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; C055774:olpadronic acid; D000077268:Pamidronate; D019386:Alendronate